Published in Int J Gynaecol Obstet on August 09, 2012
Women's health beyond reproduction: meeting the challenges. Bull World Health Organ (2012) 1.38
Redesigning primary care to tackle the global epidemic of noncommunicable disease. Am J Public Health (2015) 1.04
Why the time is right to tackle breast and cervical cancer in low-resource settings. Bull World Health Organ (2013) 0.89
Cervical and female breast cancers in the Americas: current situation and opportunities for action. Bull World Health Organ (2013) 0.83
Trends in cervical cancer in Fiji, 2000-2010. Public Health Action (2013) 0.78
Implementation science in cancer prevention and control: a framework for research and programs in low- and middle-income countries. Cancer Epidemiol Biomarkers Prev (2014) 0.75
Mexico's path towards the Sustainable Development Goal for health: an assessment of the feasibility of reducing premature mortality by 40% by 2030. Lancet Glob Health (2016) 0.75
Levels of persistent organic pollutants in breast milk of Maya women in Yucatan, Mexico. Environ Monit Assess (2017) 0.75
Paclitaxel plus bevacizumab versus paclitaxel alone for metastatic breast cancer. N Engl J Med (2007) 20.19
Global health 2035: a world converging within a generation. Lancet (2013) 16.85
Expansion of cancer care and control in countries of low and middle income: a call to action. Lancet (2010) 6.84
American Society of Clinical Oncology technology assessment on the use of aromatase inhibitors as adjuvant therapy for postmenopausal women with hormone receptor-positive breast cancer: status report 2004. J Clin Oncol (2004) 6.59
Caesarean delivery rates and pregnancy outcomes: the 2005 WHO global survey on maternal and perinatal health in Latin America. Lancet (2006) 6.56
Maternal and neonatal individual risks and benefits associated with caesarean delivery: multicentre prospective study. BMJ (2007) 4.92
Goserelin for ovarian protection during breast-cancer adjuvant chemotherapy. N Engl J Med (2015) 4.53
The Global Campaign for the Health MDGs: challenges, opportunities, and the imperative of shared learning. Lancet (2007) 3.86
American Society of Clinical Oncology 2003 update on the role of bisphosphonates and bone health issues in women with breast cancer. J Clin Oncol (2003) 3.71
The quest for universal health coverage: achieving social protection for all in Mexico. Lancet (2012) 3.48
Evidence is good for your health system: policy reform to remedy catastrophic and impoverishing health spending in Mexico. Lancet (2006) 3.20
Mandatory second opinion to reduce rates of unnecessary caesarean sections in Latin America: a cluster randomised controlled trial. Lancet (2004) 2.59
Health metrics and evaluation: strengthening the science. Lancet (2008) 2.55
Multidisciplinary meeting on male breast cancer: summary and research recommendations. J Clin Oncol (2010) 2.53
Where is the "E" in MCH? The need for an evidence-based approach in safe motherhood. J Midwifery Womens Health (2003) 2.36
Instituto Carso de la Salud: a boost for health philanthropy. Lancet (2008) 2.24
Health insurance in Mexico: achieving universal coverage through structural reform. Health Aff (Millwood) (2005) 2.22
Major depression after breast cancer: a review of epidemiology and treatment. Gen Hosp Psychiatry (2008) 2.21
Methodological considerations in implementing the WHO Global Survey for Monitoring Maternal and Perinatal Health. Bull World Health Organ (2008) 2.15
Effects of denosumab in patients with bone metastases with and without previous bisphosphonate exposure. J Bone Miner Res (2010) 2.15
Education of health professionals for the 21st century: a global independent Commission. Lancet (2010) 2.10
Ranking 37th--measuring the performance of the U.S. health care system. N Engl J Med (2010) 2.07
Predictability of adjuvant trastuzumab benefit in N9831 patients using the ASCO/CAP HER2-positivity criteria. J Natl Cancer Inst (2011) 1.94
Practical guidelines for the prevention, diagnosis, and treatment of osteonecrosis of the jaw in patients with cancer. J Oncol Pract (2006) 1.84
The Lancet-University of Oslo Commission on Global Governance for Health, in collaboration with the Harvard Global Health Institute. Lancet (2011) 1.78
Value-of-information analysis within a stakeholder-driven research prioritization process in a US setting: an application in cancer genomics. Med Decis Making (2013) 1.70
Patient training in cancer pain management using integrated print and video materials: a multisite randomized controlled trial. Pain (2008) 1.69
Clinical cancer advances 2008: major research advances in cancer treatment, prevention, and screening--a report from the American Society of Clinical Oncology. J Clin Oncol (2008) 1.69
Promoting evidence based practice in maternal care. BMJ (2002) 1.68
American Society of Clinical Oncology technology assessment working group update: use of aromatase inhibitors in the adjuvant setting. J Clin Oncol (2003) 1.64
Clinical cancer advances 2006: major research advances in cancer treatment, prevention, and screening--a report from the American Society of Clinical Oncology. J Clin Oncol (2006) 1.64
Intracluster correlation coefficients from the 2005 WHO Global Survey on Maternal and Perinatal Health: implications for implementation research. Paediatr Perinat Epidemiol (2008) 1.56
Adherence and persistence with oral adjuvant chemotherapy in older women with early-stage breast cancer in CALGB 49907: adherence companion study 60104. J Clin Oncol (2010) 1.44
Women's health beyond reproduction: meeting the challenges. Bull World Health Organ (2012) 1.38
Approaches to improve the quality of maternal and newborn health care: an overview of the evidence. Reprod Health (2014) 1.37
Womens' opinions on antenatal care in developing countries: results of a study in Cuba, Thailand, Saudi Arabia and Argentina. BMC Public Health (2003) 1.34
American Society of Clinical Oncology technology assessment on the use of aromatase inhibitors as adjuvant therapy for women with hormone receptor-positive breast cancer: status report 2002. J Clin Oncol (2002) 1.32
Measuring coverage in MNCH: validating women's self-report of emergency cesarean sections in Ghana and the Dominican Republic. PLoS One (2013) 1.26
Setting research priorities for preconception care in low- and middle-income countries: aiming to reduce maternal and child mortality and morbidity. PLoS Med (2013) 1.26
Breast cancer in Mexico: a pressing priority. Reprod Health Matters (2008) 1.20
Innovative financing for health: what is truly innovative? Lancet (2012) 1.19
Disrespect and abuse during childbirth in Tanzania: are women living with HIV more vulnerable? J Acquir Immune Defic Syndr (2014) 1.18
Approaches to improve quality of care (QoC) for women and newborns: conclusions, evidence gaps and research priorities. Reprod Health (2014) 1.17
Impact of FDG PET on defining the extent of disease and on the treatment of patients with recurrent or metastatic breast cancer. AJR Am J Roentgenol (2004) 1.16
WHO global survey on maternal and perinatal health in Latin America: classifying caesarean sections. Reprod Health (2009) 1.14
Household catastrophic health expenditures: a comparative analysis of twelve Latin American and Caribbean Countries. Salud Publica Mex (2011) 1.13
[The health system of Mexico]. Salud Publica Mex (2011) 1.12
Phase I/II study of ixabepilone plus capecitabine in anthracycline-pretreated/resistant and taxane-resistant metastatic breast cancer. Clin Breast Cancer (2008) 1.04
Current treatment options in triple negative breast cancer. Breast Dis (2010) 1.04
[The health care costs of breast cancer: the case of the Mexican Social Security Institute]. Salud Publica Mex (2009) 1.02
Homocysteine and B vitamins relate to brain volume and white-matter changes in geriatric patients with psychiatric disorders. Am J Geriatr Psychiatry (2004) 1.02
A phase II study of imatinib mesylate and capecitabine in metastatic breast cancer: Southwest Oncology Group Study 0338. Clin Breast Cancer (2008) 1.02
The growing movement for universal health coverage. Lancet (2011) 1.01
Improving global health education: development of a Global Health Competency Model. Am J Trop Med Hyg (2014) 1.01
Health systems integration of sexual and reproductive health and HIV services in sub-Saharan Africa: a scoping study. J Acquir Immune Defic Syndr (2014) 0.99
Keeping promises for women and children. Lancet (2012) 0.99
[Financial protection in health: Mexico, 1992 to 2004]. Salud Publica Mex (2006) 0.97
GBD 2.0: a continuously updated global resource. Lancet (2013) 0.96
[Fair health financing and catastrophic health expenditures: potential impact of the coverage extension of the popular health insurance in Mexico]. Salud Publica Mex (2005) 0.95
Towards comprehensive women's healthcare in sub-Saharan Africa: addressing intersections between HIV, reproductive and maternal health. J Acquir Immune Defic Syndr (2014) 0.94
A multi-country study of the "intrapartum stillbirth and early neonatal death indicator" in hospitals in low-resource settings. Int J Gynaecol Obstet (2013) 0.94
[Breast cancer in Mexico: an urgent priority]. Salud Publica Mex (2009) 0.93
Magnesium sulfate is not used for pre-eclampsia and eclampsia in Mexico and Thailand as much as it should be. Bull World Health Organ (2007) 0.92
Pooled analysis of individual patient data from capecitabine monotherapy clinical trials in locally advanced or metastatic breast cancer. Breast Cancer Res Treat (2012) 0.91
Emergency contraception in Mexico City: knowledge, attitudes, and practices among providers and potential clients after a 3-year introduction effort. Contraception (2002) 0.91
Information campaign and advocacy efforts to promote access to emergency contraception in Mexico. Contraception (2002) 0.90
Cluster randomized trial of an active, multifaceted information dissemination intervention based on The WHO Reproductive health library to change obstetric practices: methods and design issues [ISRCTN14055385]. BMC Med Res Methodol (2004) 0.88
Eliminating preventable HIV-related maternal mortality in sub-Saharan Africa: what do we need to know? J Acquir Immune Defic Syndr (2014) 0.87
Breast cancer: why link early detection to reproductive health interventions in developing countries? Salud Publica Mex (2009) 0.86
A comprehensive approach to women's health: lessons from the Mexican health reform. BMC Womens Health (2012) 0.86
Structural and functional studies on the interaction of adenovirus fiber knobs and desmoglein 2. J Virol (2013) 0.85
Women and Health Initiative: integrating needs and response. Lancet (2011) 0.84
Course of depression, mental health service utilization and treatment preferences in women receiving chemotherapy for breast cancer. Gen Hosp Psychiatry (2013) 0.83
[The quest for universal health coverage: achieving social protection for all in Mexico]. Salud Publica Mex (2013) 0.83
Deaths from complications of unsafe abortion: misclassified second trimester deaths. Reprod Health Matters (2004) 0.83
[Evidence is good for your health system: policy reform to remedy catastrophic and impoverishing health spending in Mexico]. Salud Publica Mex (2007) 0.83
Impact of c-MYC protein expression on outcome of patients with early-stage HER2+ breast cancer treated with adjuvant trastuzumab NCCTG (alliance) N9831. Clin Cancer Res (2013) 0.82
A phase II trial of pemetrexed and gemcitabine in patients with metastatic breast cancer who have received prior taxane therapy. Clin Breast Cancer (2010) 0.82
Reducing maternal mortality: a global imperative. Contraception (2010) 0.82
Women's and children's health: from pledges to action. Bull World Health Organ (2010) 0.82
Group Carso, health philanthropy, and tobacco. Lancet (2008) 0.82
Improving pathology for better cancer care and control in countries of low and middle income. Lancet (2012) 0.82
Recommendations towards an integrated, life-course approach to women's health in the post-2015 agenda. Bull World Health Organ (2013) 0.81
Who assessment of health systems performance. Lancet (2003) 0.80
A new initiative and invitation for health monitoring, tracking, and evaluation. Lancet (2008) 0.80
[Building awareness, promoting early detection and combating prejudices: keys in the fight against breast cancer]. Salud Publica Mex (2009) 0.80
Is induced abortion a contributing factor to tubal infertility in Mexico? Evidence from a case-control study. BJOG (2004) 0.80
[Situational profile and intervention strategy in the Mesoamerican region in maternal, neonatal and reproductive health area]. Salud Publica Mex (2011) 0.78
The new women's health agenda. Bull World Health Organ (2013) 0.78